4.8 Article

Aberrant L-Fucose Accumulation and Increased Core Fucosylation Are Metabolic Liabilities in Mesenchymal Glioblastoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast Cancers

Chengheng Liao et al.

Summary: Metabolic dysregulation in breast cancer was characterized and divided into two major metabolic groups. Genes strongly correlated with metabolic dysregulation and predicted patient prognosis were identified. Targeting metabolic dysregulation led to effective therapeutic outcomes. This study is of great significance in guiding therapeutic strategies for breast cancer subsets.

CANCER RESEARCH (2022)

Review Biochemistry & Molecular Biology

FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer

Kayla Bastian et al.

Summary: Aberrant glycosylation, particularly altered core fucosylation driven by FUT8, is a universal feature of cancer cells impacting tumor progression. Upregulated FUT8 plays critical roles in immune evasion and cancer development, outlining potential opportunities for future therapeutics targeting FUT8.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Proteogenomic and metabolomic characterization of human glioblastoma

Liang-Bo Wang et al.

Summary: Understanding the molecular pathogenesis of glioblastoma is crucial for improving diagnosis and treatment. Integrated analysis of genomic, proteomic, and metabolomic data on treatment-naive glioblastomas has identified key phosphorylation events and potential targets for specific tumor alterations. Immune subtypes with distinct immune cell types were discovered, and specific histone acetylation patterns were correlated with these subtypes, providing insights for stratification of patients for more effective treatment.

CANCER CELL (2021)

Review Oncology

Diffuse Glioma Heterogeneity and Its Therapeutic Implications

James G. Nicholson et al.

Summary: Diffuse gliomas are characterized by high levels of genetic, epigenetic, and environmental heterogeneity, leading to extreme phenotypic heterogeneity at the cellular level and resistance to various therapies. The intratumoral heterogeneity and malignant cell state plasticity in gliomas pose significant challenges to the development of novel targeted therapies.

CANCER DISCOVERY (2021)

Article Oncology

Oncometabolites in Cancer: Current Understanding and Challenges

Yang Liu et al.

Summary: Oncometabolites are characteristic hallmarks of various human cancers, generated from disrupted Krebs cycle and impacting the activity of certain enzymes. They signify different cancer-related patterns and understanding the relationship between cancer and oncometabolites could lead to novel therapeutic approaches for improved cancer treatment.

CANCER RESEARCH (2021)

Review Pharmacology & Pharmacy

Convection Enhanced Delivery in the Setting of High-Grade Gliomas

Chibueze D. Nwagwu et al.

Summary: This review discusses the potential of convection-enhanced delivery (CED) in treating high-grade gliomas by directly delivering homogeneous drug concentrations to the site of disease, which can significantly limit systemic toxicity and enhance therapeutic effectiveness.

PHARMACEUTICS (2021)

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights

Zhiqiang Pang et al.

Summary: MetaboAnalyst version 5.0 has been introduced to facilitate comprehensive metabolomics data analysis and interpretation, with the aim of narrowing the gap from raw data to functional insights. Three new modules have been developed to assist in this goal, along with various other new functions and improvements in interface, graphics, and codebase. Users can now easily switch between compatible modules for a streamlined data analysis experience.

NUCLEIC ACIDS RESEARCH (2021)

Article Oncology

First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors

Khanh T. Do et al.

Summary: SGN-2FF, a potent small-molecule inhibitor of glycoprotein fucosylation, demonstrated dose-proportional pharmacokinetics, evidence of pharmacodynamic target inhibition of glycoprotein fucosylation, and preliminary antitumor activity in advanced solid tumors. However, it was associated with thromboembolic events that led to study termination.

ONCOLOGIST (2021)

Article Oncology

Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma

Francesca Puca et al.

Summary: The study reveals a high dependence of glioblastoma on mitochondrial fatty acid metabolism, specifically medium-chain acyl-CoA dehydrogenase (MCAD), with depletion leading to detrimental metabolic effects and cell death. The research highlights a potential therapeutic target in exploiting the key metabolic feature of GBM related to MCFA catabolism.

CANCER DISCOVERY (2021)

Review Oncology

Metabolic Rewiring and the Characterization of Oncometabolites

Diren Beyoglu et al.

Summary: Oncometabolites are produced by cancer cells, facilitating cancer proliferation and progression. Metabolomics, utilizing mass spectrometry platforms, has defined the metabolic changes in cancer cells and uncovered potential oncometabolites.

CANCERS (2021)

Article Medicine, Research & Experimental

Severe consequences of a high-lipid diet include hydrogen sulfide dysfunction and enhanced aggression in glioblastoma

Daniel J. Silver et al.

Summary: Research shows that consuming a high-fat diet may worsen glioblastoma (GBM), mainly by inhibiting the production of hydrogen sulfide (H2S) and increasing the enrichment of cancer stem cells (CSC). Increasing the bioavailability of H2S may help suppress the development of GBM.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Oncology

Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity

Laura M. Richards et al.

Summary: The study revealed that glioblastomas contain diverse cell populations, with GSCs showing high transcriptional heterogeneity associated with normal neural development and inflammatory wound response. Genome-wide CRISPR-Cas9 dropout screens validated this observation. Additionally, the majority of malignant cells were found to organize along an orthogonal astrocyte maturation gradient while retaining founder GSC transcriptional programs.

NATURE CANCER (2021)

Review Oncology

FUT8 and Protein Core Fucosylation in Tumours: From Diagnosis to Treatment

Chengcheng Liao et al.

Summary: The research highlights the association between FUT8 and core fucosylation in various tumors, suggesting their potential as markers for cancer diagnosis and prognosis, as well as providing potential targets for tumor therapy. Additionally, defucosylation of IGg1 antibodies may enhance antibody affinity, presenting another avenue for tumor therapy utilizing FUT8.

JOURNAL OF CANCER (2021)

Article Oncology

Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities

Luciano Garofano et al.

Summary: Garofano et al. classified glioblastomas into subtypes along metabolic and neurodevelopmental axes using single-cell RNA-sequencing data. Mitochondrial GBM showed the most favorable clinical outcome and vulnerability to inhibitors of oxidative phosphorylation, while glycolytic/plurimetabolic GBM relied on aerobic glycolysis and other metabolic pathways for energy production. This pathway-based classification can inform survival and precision targeting of cancer metabolism.

NATURE CANCER (2021)

Article Biochemistry & Molecular Biology

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

Cyril Neftel et al.

Review Cell Biology

Mechanisms and Implications of Metabolic Heterogeneity in Cancer

Jiyeon Kim et al.

CELL METABOLISM (2019)

Article Cell Biology

Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells

Xiuxing Wang et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Review Biochemistry & Molecular Biology

Unmasking Fucosylation: from Cell Adhesion to Immune System Regulation and Diseases

Jun Li et al.

CELL CHEMICAL BIOLOGY (2018)

Review Biochemistry & Molecular Biology

Biological functions of fucose in mammals

Michael Schneider et al.

GLYCOBIOLOGY (2017)

Article Neurosciences

Purine synthesis promotes maintenance of brain tumor initiating cells in glioma

Xiuxing Wang et al.

NATURE NEUROSCIENCE (2017)

Article Biochemistry & Molecular Biology

An Alkynyl-Fucose Halts Hepatoma Cell Migration and Invasion by Inhibiting GDP-Fucose-Synthesizing Enzyme FX, TSTA3

Yasuhiko Kizuka et al.

CELL CHEMICAL BIOLOGY (2017)

Review Medical Laboratory Technology

Oncometabolites: A New Paradigm for Oncology, Metabolism, and the Clinical Laboratory

Rebecca R. J. Collins et al.

CLINICAL CHEMISTRY (2017)

Article Cell & Tissue Engineering

Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma

Tobias L. Haas et al.

CELL STEM CELL (2017)

Article Medicine, Research & Experimental

Nicotinamide metabolism regulates glioblastoma stem cell maintenance

Jinkyu Jung et al.

JCI INSIGHT (2017)

Review Biochemistry & Molecular Biology

Oncometabolites: Unconventional triggers of oncogenic signalling cascades

Marco Sciacovelli et al.

FREE RADICAL BIOLOGY AND MEDICINE (2016)

Review Clinical Neurology

The role of CD44 in glioblastoma multiforme

Kelly L. Mooney et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2016)

Article Oncology

Large-scale assessment of the gliomasphere model system

Dan R. Laks et al.

NEURO-ONCOLOGY (2016)

Article Cell Biology

Origin of the U87MG glioma cell line: Good news and bad news

Marie Allen et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

Article Biochemistry & Molecular Biology

Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer

Xiangchun Wang et al.

GLYCOBIOLOGY (2014)

Article Multidisciplinary Sciences

ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers

Alexander Augustyn et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Multidisciplinary Sciences

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

Anoop P. Patel et al.

SCIENCE (2014)

Article Oncology

Integrin α3 is overexpressed in glioma stem-like cells and promotes invasion

M. Nakada et al.

BRITISH JOURNAL OF CANCER (2013)

Article Multidisciplinary Sciences

Development of orally active inhibitors of protein and cellular fucosylation

Nicole M. Okeley et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Cell & Tissue Engineering

Integrin Alpha 6 Regulates Glioblastoma Stem Cells

Justin D. Lathia et al.

CELL STEM CELL (2010)

Article Biochemical Research Methods

Neural stem cells and neurospheres - re-evaluating the relationship

BA Reynolds et al.

NATURE METHODS (2005)